Overview
Shinichiro Nakajima practices in Toronto, Canada. Nakajima is rated as an Elite expert by MediFind in the treatment of Schizophrenia. Their top areas of expertise are Schizophrenia, Major Depression, Autism Spectrum Disorder, and Bipolar Disorder (BPD).
Their clinical research consists of co-authoring 207 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 73 articles and participated in 1 clinical trial in the study of Schizophrenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- SchizophreniaNakajima isElite. Learn about Schizophrenia.
- Advanced
- Autism Spectrum DisorderNakajima isAdvanced. Learn about Autism Spectrum Disorder.
- Bipolar Disorder (BPD)Nakajima isAdvanced. Learn about Bipolar Disorder (BPD).
- Major DepressionNakajima isAdvanced. Learn about Major Depression.
- Experienced
- AgnosiaNakajima isExperienced. Learn about Agnosia.
- Alzheimer's DiseaseNakajima isExperienced. Learn about Alzheimer's Disease.
- Attention Deficit Hyperactivity Disorder (ADHD)
- DeliriumNakajima isExperienced. Learn about Delirium.
- DementiaNakajima isExperienced. Learn about Dementia.
- Developmental Dysphasia FamilialNakajima isExperienced. Learn about Developmental Dysphasia Familial.